{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T01:40:13Z","timestamp":1791337213902,"version":"4.3.1"},"reference-count":31,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,12,17]],"date-time":"2014-12-17T00:00:00Z","timestamp":1418774400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Med Oncol"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1007\/s12032-014-0451-4","type":"journal-article","created":{"date-parts":[[2014,12,16]],"date-time":"2014-12-16T12:58:36Z","timestamp":1418734716000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":22,"title":["Clinicopathological features, vitamin D serological levels and prognosis in cutaneous melanoma of shield-sites: an update"],"prefix":"10.1007","volume":"32","author":[{"given":"Giovanni","family":"Paolino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Moliterni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Didona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Garelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Corsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Giovanni","family":"Richetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Cantisani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ugo","family":"Bottoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Calvieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,17]]},"reference":[{"key":"451_CR1","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jaad.2014.01.910","volume":"71","author":"LX Tong","year":"2014","unstructured":"Tong LX, Young LC. Nutrition: the future of melanoma prevention? J Am Acad Dermatol. 2014;71:151\u201360.","journal-title":"J Am Acad Dermatol"},{"key":"451_CR2","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/ajd.12033","volume":"54","author":"S Ghattas","year":"2013","unstructured":"Ghattas S, Howle J, Wang W, et al. Intravascular metastatic melanoma: a difficult diagnosis. Australas J Dermatol. 2013;54:141\u20133.","journal-title":"Australas J Dermatol"},{"key":"451_CR3","first-page":"259","volume":"153","author":"J Alcalay","year":"2014","unstructured":"Alcalay J. Lentigo maligna: a diagnostic and therapeutic challenge. Harefuah. 2014;153:259\u201360 306,305.","journal-title":"Harefuah."},{"key":"451_CR4","unstructured":"Robbins SL, Cotran RS. Pathologic basis of disease. Saunders. 2014; 9th ed."},{"key":"451_CR5","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1146\/annurev-pharmtox-010510-100611","volume":"51","author":"AV Krishnan","year":"2011","unstructured":"Krishnan AV, Feldman D. Mechanism of the anti-cancer and anti-inflammatory actions of vitamin D. Annu Rev Pharmacol Toxicol. 2011;51:311\u201336.","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"451_CR6","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.humpath.2010.09.014","volume":"42","author":"AA Brozyna","year":"2011","unstructured":"Brozyna AA, Jozwicki W, Janjetovic Z, et al. Expression of vitamin D receptor (VDR) decreases during progression of pigmented skin lesions. Hum Pathol. 2011;42:618\u201331.","journal-title":"Hum Pathol"},{"key":"451_CR7","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.humpath.2012.03.031","volume":"44","author":"AA Brozyna","year":"2013","unstructured":"Brozyna AA, Jozwicki W, Janjetovic Z, et al. Expression of vitamin D-activating enzyme 1\u03b1-hydroxylase (CYP27B1) decreases during melanoma progression. Hum Pathol. 2013;44:374\u201387.","journal-title":"Hum Pathol"},{"key":"451_CR8","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1111\/j.1468-3083.2011.04023.x","volume":"25","author":"E Micu","year":"2011","unstructured":"Micu E, Juzeniene M, Moan J. Comparison of the time and latitude trends of melanoma incidence in anorectal region and perianal skin with those of cutaneous malignant melanoma in Norway. J Eur Acad Dermatol Venereol. 2011;25:1444\u20139.","journal-title":"J Eur Acad Dermatol Venereol"},{"key":"451_CR9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/joim.12251","volume":"276","author":"PG Lindqvist","year":"2014","unstructured":"Lindqvist PG, Epstein E, Landin-Olsson M, et al. Avoidance of sun exposure is a risk factor for all-cause mortality: results from the Melanoma in Southern Sweden cohort. J Int Med. 2014;276:77\u201386.","journal-title":"J Int Med"},{"key":"451_CR10","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s10552-009-9470-4","volume":"21","author":"JY Tang","year":"2010","unstructured":"Tang JY, Parimi N, Wu A, et al. Osteoporotic Fractures in Men (MrOS) Study Group. Inverse association between serum 25(OH) vitamin D levels and non-melanoma skin cancer in elderly men. Cancer Causes Control. 2010;21:387\u201391.","journal-title":"Cancer Causes Control"},{"key":"451_CR11","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1056\/NEJMra052166","volume":"355","author":"AJ Miller","year":"2006","unstructured":"Miller AJ, Mihm MC Jr. Melanoma. N Engl J Med. 2006;355:51\u201365.","journal-title":"N Engl J Med"},{"key":"451_CR12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.jphotobiol.2010.03.003","volume":"101","author":"J Moan","year":"2010","unstructured":"Moan J, Porojnicu AC, Dahlback A, et al. Where the sun does not shine: is sunshine protective against melanoma of the vulva? J Photochem Photobiol B. 2010;101:179\u201383.","journal-title":"J Photochem Photobiol B"},{"key":"451_CR13","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/978-1-4899-2406-3_10","volume-title":"Environmental UV photobiology","author":"J Moan","year":"1993","unstructured":"Moan J, Dahlback A. Ultraviolet radiation and skin cancer: epidemiological data from Scandinavia. In: Young AR, Young A, Bjorn LO, Moan J, Nultsch W, editors. Environmental UV photobiology. New York: Plenum Press; 1993. p. 255\u201393."},{"key":"451_CR14","doi-asserted-by":"crossref","unstructured":"Dabouz F, Barbe C, Lesage C, et al. Clinical and histological features of head and neck melanoma: a population-based study in France. Br J Dermatol. 2014.","DOI":"10.1111\/bjd.13489"},{"key":"451_CR15","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1001\/archdermatol.2012.2937","volume":"148","author":"F Grange","year":"2012","unstructured":"Grange F, Barbe C, Aubin F, et al. Clinical and sociodemographic characteristics associated with thick melanomas: a population-based, case\u2013case study in France. Arch Dermatol. 2012;148:1370\u20136.","journal-title":"Arch Dermatol"},{"key":"451_CR16","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1046\/j.1365-2133.2001.04071.x","volume":"144","author":"JE Osborne","year":"2001","unstructured":"Osborne JE, Hutchinson PE. Clinical correlates of Breslow thickness of malignant melanoma. Br J Dermatol. 2001;144:476\u201383.","journal-title":"Br J Dermatol"},{"key":"451_CR17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/archderm.144.5.629","volume":"144","author":"F Grange","year":"2008","unstructured":"Grange F, Vitry F, Granel-Brocard F, et al. Variations in management of stage I to stage III cutaneous melanoma: a population-based study of clinical practices in France. Arch Dermatol. 2008;144:629\u201336.","journal-title":"Arch Dermatol"},{"key":"451_CR18","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1186\/1471-2407-14-780","volume":"14","author":"RP Saw","year":"2014","unstructured":"Saw RP, Armstrong BK, Mason RS, et al. Adjuvant therapy with high dose vitamin D following primary treatment of melanoma at high risk of recurrence: a placebo controlled randomized phase II trial (ANZMTG 02.09 Mel-D). BMC Cancer. 2014;14:780.","journal-title":"BMC Cancer"},{"key":"451_CR19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.mce.2011.05.017","volume":"347","author":"DD Bikle","year":"2011","unstructured":"Bikle DD. Vitamin D metabolism and function in the skin. Mol Cell Endocrinol. 2011;347:80\u20139.","journal-title":"Mol Cell Endocrinol"},{"key":"451_CR20","first-page":"9","volume":"2","author":"L Hargrove","year":"2014","unstructured":"Hargrove L, Francis T, Francis H. Vitamin D and GI cancers: shedding some light on dark diseases. Ann Transl Med. 2014;2:9.","journal-title":"Ann Transl Med"},{"key":"451_CR21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/978-3-642-55580-0_1","volume":"164","author":"MF Holick","year":"2003","unstructured":"Holick MF. Evolution and function of vitamin D. Recent Results Cancer Res. 2003;164:3\u201328.","journal-title":"Recent Results Cancer Res"},{"key":"451_CR22","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1093\/jnci\/dji019","volume":"97","author":"M Berwick","year":"2005","unstructured":"Berwick M, Armstrong BK, Ben-Porat L, et al. Sun exposure and mortality from melanoma. J Natl Cancer Inst. 2005;97:195\u20139.","journal-title":"J Natl Cancer Inst"},{"key":"451_CR23","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1002\/ijc.21907","volume":"119","author":"EY Lee","year":"2006","unstructured":"Lee EY, Williamson R, Watt P, et al. Sun exposure and host phenotype as predictors of cutaneous melanoma associated with naval remnants or dermal elastosis. Int J Cancer. 2006;119:636\u201342.","journal-title":"Int J Cancer"},{"key":"451_CR24","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1111\/ced.12430","volume":"39","author":"C Massad","year":"2014","unstructured":"Massad C, Loya A, Taraif S, et al. BRAF mutation status in primary and metastatic melanomas in two regions with differing potential ultraviolet radiation exposure. Clin Exp Dermatol. 2014;39:932\u201343.","journal-title":"Clin Exp Dermatol"},{"key":"451_CR25","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/humu.20802","volume":"29","author":"A Besaratinia","year":"2008","unstructured":"Besaratinia A, Pfeifer GP. Sunlight, ultraviolet irradiation and BRAF V600 mutagenesis in human melanoma. Hum Mutat. 2008;29:983\u201391.","journal-title":"Hum Mutat"},{"key":"451_CR26","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/jid.2010.405","volume":"131","author":"RQ Qi","year":"2011","unstructured":"Qi RQ, He L, Zheng S, et al. BRAF exon 15 T1799A mutation is common in melanocytic nevi, but less prevalent in cutaneous malignant melanoma, in Chinese Han. J Invest Dermatol. 2011;131:1129\u201338.","journal-title":"J Invest Dermatol"},{"key":"451_CR27","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.1755-148X.2011.00837.x","volume":"24","author":"J Bauer","year":"2011","unstructured":"Bauer J, B\u00fcttner P, Murali R, et al. BRAF mutations in cutaneous melanoma are independently associated with age, anatomic site of the primary tumor, and the degree of solar elastosis at the primary tumor site. Pigment Cell Melanoma Res. 2011;24:345\u201351.","journal-title":"Pigment Cell Melanoma Res"},{"key":"451_CR28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1111\/cen.12396","volume":"81","author":"M Zou","year":"2014","unstructured":"Zou M, BinHumaid FS, Alzahrani AS, et al. Increased CYP24A1 expression is associated with BRAF(V600E) mutation and advanced stages in papillary thyroid carcinoma. Clin Endocrinol (Oxf). 2014;81:109\u201316.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"451_CR29","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1038\/nrc2196","volume":"7","author":"KK Deeb","year":"2007","unstructured":"Deeb KK, Trump DL, Johnson CS. Vitamin D signalling pathways in cancer: potential for anticancer therapeutics. Nat Rev Cancer. 2007;7:684\u2013700.","journal-title":"Nat Rev Cancer"},{"key":"451_CR30","doi-asserted-by":"crossref","first-page":"4340","DOI":"10.1200\/JCO.2006.06.2984","volume":"24","author":"JA Curtin","year":"2006","unstructured":"Curtin JA, Busam K, Pinkel D, et al. Somatic activation of KIT in distinct subtypes of melanoma. J Clin Oncol. 2006;24:4340\u20136.","journal-title":"J Clin Oncol"},{"key":"451_CR31","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1093\/jnci\/95.11.806","volume":"95","author":"DC Whiteman","year":"2003","unstructured":"Whiteman DC, Watt P, Purdie DM, et al. Melanocytic nevi, solar keratoses, and divergent pathways to cutaneous melanoma. J Natl Cancer Inst. 2003;95:806\u201312.","journal-title":"J Natl Cancer Inst"}],"container-title":["Medical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-014-0451-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12032-014-0451-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12032-014-0451-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T22:31:48Z","timestamp":1559428308000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12032-014-0451-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,17]]},"references-count":31,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["451"],"URL":"https:\/\/doi.org\/10.1007\/s12032-014-0451-4","relation":{},"ISSN":["1357-0560","1559-131X"],"issn-type":[{"value":"1357-0560","type":"print"},{"value":"1559-131X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,17]]},"article-number":"451"}}